Health Blog

Is Expensive Sunscreen Worth It?

Posted on: May 4, 2017

  Ms. Y is a 75 year old woman who noticed a dry lump on her left forearm several months ago. The lump quickly grew, and a biopsy showed squamous cell carcinoma (SCC), a type of skin cancer. She was treated with Mohs surgery, a procedure in which a dermatologist shaves off layers of skin… read more

We are QOPI Certified, Again!

Posted on: April 7, 2017

Our practice has met the Certification requirements for QOPI® Certification. This status demonstrates a commitment to excellence and ongoing quality improvement in our practice. QOPI Certification must be renewed every three years. QOPI certification reflects a commitment to quality of care that leads to fundamental changes in the clinical practice of oncology. We have achieved… read more

Understanding Anemia

Posted on: April 1, 2017

Anemia in the older adult can be a challenging diagnosis to treat, as up to 20-30% of patients may have unexplained anemia even after a thorough workup, and a good proportion of patients have multiple causes for their anemia.  It’s important to address the cause of the anemia, and in many cases also important to… read more

Add a Little Spice to Your Life

Posted on: March 1, 2017

    Curcumin is an active ingredient of turmeric, a spice widely used in curries. In many Southeast Asian countries it has been consumed in the diet on a daily basis for centuries. This daily consumption not only speaks for its safety but has been said to be responsible for the low incidence of colorectal… read more

A Vaccine for Cancer is Here

Posted on: February 1, 2017

This year the California Department of Public Health is holding a preteen vaccine week February 12th through 18th. The Advisory Committee on Immunization Practices recommends that 11 and 12 year olds have the Tdap (required), Meningococcal, Influenza, Chickenpox and HPV vaccines before entering into 7th grade. As a medical oncologist I encourage all parents to… read more

Practice Changing Hematology Updates

Posted on: January 4, 2017

This year’s meeting of the American Society of Hematology (ASH),  held this year in San Diego, CA, was less noticeable for blockbuster announcements than many potentially practice changing presentations. For patients with chronic lymphocytic leukemia (CLL), the use of Obinatuzumab (Gazyva), in combination with standard chemotherapy, was superior to the use of the standard therapy… read more